A new UK study highlights the effectiveness of type 2 diabetes screening in pharmacies. This inexpensive method would improve early diagnosis and significantly reduce the costs of the disease.
Tracking Type 2 Diabetes in Pharmacy with a Blood Glucose Meter: This may be the key to early diagnosis and better management of the disease.
While the French Institute for Health Surveillance estimates that diabetes affects nearly 3.3 million people in France, or 5% of the population, a new study conducted by researchers at the University of East Anglia (UEA) and from Boots UK demonstrates the effectiveness of pediatric disease screening. Their results are published in the journal Pharmacy.
20 to 30% of undiagnosed adults with diabetes
Also called non-insulin-dependent diabetes, type 2 diabetes is characterized by an abnormally high and chronic level of sugar in the blood (hyperglycemia). At issue: a lack of insulin, a hormone produced by the pancreas, which naturally regulates the level of glucose present in the blood. In France, 90% of diabetics are concerned by this insidious disease and can, in the long term, have serious consequences or even death.
Several studies have already shown that the early identification and treatment of diabetes is known to reduce the incidence of complications and thus the cost of disease for the public authorities. In particular, it is estimated that the provision of screening services to populations allows the diagnosis of the disease up to 3.3 years earlier on average. Screening for type 2 diabetes is therefore a major public health issue, especially since it is estimated that currently 20 to 30% of adults with diabetes are undiagnosed.
An effective and inexpensive method
To investigate the effectiveness and cost-effectiveness of type 2 diabetes screening in pharmacy, English researchers focused on two areas experimenting with the device: Leicester and Surrey. A total of 328 people participated in the study, which was conducted over a six-month period in 2014. They found that the cost per test and patient identification rates were similar to those reported by the practices. medical conditions for type 2 diabetes.
According to the researchers, allowing pharmacies to offer type 2 diabetes screening services in areas of higher prevalence would greatly improve the cost-effectiveness of these services. "This study shows that drug testing in pharmacies is no more expensive or less effective than screening by other means, but for these services to be cost-effective, we also need to work with those identified as 'at risk'. "to prevent progression to diabetes," says Professor David Wright, of the UEA School of Pharmacy and lead author of the work.
A real opportunity
"This is a natural addition to the diabetes screening process and, with appropriate funding, is something pharmacists can do effectively to contribute to the public health agenda," he says. shared by Marc Donovan, Chief Pharmacist at Boots UK, who also participated in the study: "This research highlights that there is a real opportunity for pharmacies in the UK to offer community-based diabetes screenings. type 2 and continue to support the services offered by general practitioners' offices. "
In France, screening for type 2 diabetes has already been tested in 2017 in pharmacies in three départements in the Grand-Est region (the Ardennes, Haut-Rhin and Meurthe-et-Moselle).